Inventiva ADR
Inventiva ADR (IVA) Option Chain
As of September 18, 2026, Inventiva ADR is trading at $3.78, a +0.80% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 140.0%. IV Rank is —%.
Read more
Tracking the IVA option chain helps you see every strike and expiry on Inventiva ADR in one view, so you can quickly identify the contracts that fit your thesis and your risk. Inventiva ADR's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of IVA options activity at a glance. Use our scanner to monitor the IVA option chain in real time and filter for the IVA options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For IVA stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the IVA option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where IVA stock options are being actively traded and where they are not.
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of MPS VI subtype disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company has strategic collaboration with AbbVie for the treatment of autoimmune diseases; and Boehringer Ingelheim International GmbH for developing new treatments for idiopathic pulmonary fibrosis.
Inventiva S.A. was founded in 2011 and is based in Daix, France.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Inventiva ADR's full chain across every expiry, highlights the most liquid strikes, and lets you screen IVA options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of IVA stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile—
- Market cap (M$)893
- 52 weeks high-52.63%
- 52 weeks low12.84%
- Analyst recommendationStrong Buy
1.00 - Target price$13.83
265.87% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-09-25
- P/E—
- Future P/E—
- EPS (ttm)-2.84
- EPS growth next 5 years54.17%
As of September 18, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 18.45 | 0 | 0 | 3.72 | 1.28 | — | 5.00 | 2.50 | -33.86 | — | 0.30 | 0.00 | 0.30 | 0 | 30 | 81.55 |
| 81.99 | 15 | 0 | 5.00 | 0.00 | — | 5.00 | 5.00 | +32.28 | — | 1.50 | 1.22 | 0.28 | 0 | 2 | 18.01 |
| 97.59 | 0 | 0 | 1.05 | 0.00 | — | 1.05 | 7.50 | +98.41 | 1.50 | 6.00 | 3.72 | 0.03 | 0 | 0 | 2.41 |
As of September 18, 2026
Scan the full option chain in one place
Browse the full IVA option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→